On this page
Referral and warning signs
When to refer
Refer to higher level/specialist for: Hypertensive emergency. Hypertensive urgency requiring admission/parenteral therapy. Resistant hypertension (uncontrolled despite ≥3 drugs including diuretic). Suspected secondary hypertension. Significant target organ damage requiring specialist management.
Red flags
- Symptoms of hypertensive emergency (severe headache, confusion, seizure, visual disturbance, chest pain, severe dyspnoea, focal neurological deficit)
- BP >180/110 mmHg with signs of acute target organ damage
- Rapidly worsening renal function
- Signs of severe hypertensive retinopathy (papilloedema)
Signs and symptoms
- Usually asymptomatic (often detected during routine screening).
- May have non-specific symptoms: Headache (especially occipital, morning), dizziness, palpitations, fatigue, epistaxis.
- May present with symptoms of complications (Target Organ Damage):
- - Brain: Stroke symptoms (focal deficit, confusion), hypertensive encephalopathy (severe headache, confusion, seizures, visual disturbance).
- - Heart: Chest pain (angina/MI), dyspnoea (heart failure), palpitations.
- - Kidneys: Oedema, symptoms of renal failure (fatigue, anorexia).
- - Eyes: Blurred vision, visual field defects (hypertensive retinopathy).
- - Peripheral Arteries: Claudication.
Risk factors
- Family history of hypertension
- Increasing age
- African ancestry
- Obesity / Overweight
- Physical inactivity
- High sodium (salt) intake
- Excessive alcohol consumption
- Smoking
- Diabetes mellitus
- Dyslipidemia
- Chronic kidney disease
- Stress
Diagnosis
Clinical assessment
Diagnosis requires multiple BP readings ≥140/90 mmHg taken on at least 2-3 separate occasions, 1 week apart, with proper technique (seated, rested, appropriate cuff size). Classification: Normal (<120/80), Pre-hypertension (120-139/80-89), Stage 1 (140-159/90-99), Stage 2 (≥160/100). Assess for secondary causes (rare, suspect if young onset, resistant HTN, specific features) and target organ damage. Differentiate from 'white coat hypertension'.
Investigations
- Accurate BP measurement (multiple readings, multiple visits). Ambulatory BP monitoring (ABPM) or Home BP monitoring (HBPM) can be useful.
- Urinalysis (proteinuria, haematuria - kidney damage).
- Blood tests: Urea & Electrolytes (renal function, potassium levels - relevant for diuretics/ACEi/ARBs), Creatinine (calculate eGFR), Fasting Blood Glucose (diabetes), Lipid profile.
- ECG (assess for Left Ventricular Hypertrophy - LVH, ischaemia, arrhythmia).
- Fundoscopy (assess for hypertensive retinopathy).
- Further investigations if secondary cause suspected (e.g., renal ultrasound, endocrine tests).
Diagnostic criteria
Average BP ≥140/90 mmHg on 2-3 office visits OR based on ABPM/HBPM criteria.
Management
Non-pharmacological management
- Lifestyle Modifications (Foundation of management for all stages):
- - Salt Restriction: Reduce intake (<5-6g NaCl/day, avoid adding salt).
- - Weight Reduction: Aim for healthy BMI.
- - Healthy Diet: Emphasize fruits, vegetables, whole grains, low-fat dairy (DASH diet principles).
- - Regular Physical Activity: Aerobic exercise (e.g., brisk walking) ≥150 min/week.
- - Moderate Alcohol Consumption: Limit intake.
- - Smoking Cessation.
Pharmacological treatment
- Initiate drug therapy based on BP level and cardiovascular risk.
- - Stage 1 HTN: Start drugs if lifestyle modification fails (after ~3 months) OR if high cardiovascular risk/target organ damage present initially.
- - Stage 2 HTN: Start drug therapy immediately along with lifestyle changes.
- Stepwise Approach (UCG 2023):
- - Step 1 (Stage 1 after lifestyle failure): Amlodipine 5mg OD.
- - Step 2 (If uncontrolled on Step 1, or initial therapy for Stage 2): Amlodipine 5mg OD + ARB (Losartan 50mg / Valsartan 80mg / Telmisartan 40mg OD) OR ACEi (Lisinopril 20mg / Enalapril 5mg OD).
- - Step 3 (If uncontrolled on Step 2): Increase Amlodipine to 10mg OD + ARB/ACEi (as above).
- - Step 4 (If uncontrolled on Step 3): Amlodipine 10mg OD + ARB (Increase dose: Losartan 100mg / Valsartan 160mg / Telmisartan 80mg OD) / ACEi (Increase dose) + Thiazide diuretic (Hydrochlorothiazide 12.5-25mg OD morning / Bendroflumethiazide 2.5-5mg OD morning).
- - Step 5 (If uncontrolled on Step 4): Refer for specialist management (consider adding Spironolactone or Beta-blocker).
- Specific Patient Groups:
- - High CVD Risk (Diabetes, CKD, previous Stroke/MI): Target BP <130/80 mmHg. Start statin (Atorvastatin 20-40mg or Simvastatin 20-40mg) and Aspirin 75mg (if prior MI/ischemic stroke). Consider statin if high risk.
- - Post-MI (<3 years): Include Beta-blocker (Atenolol 50mg, Bisoprolol 5mg, Nebivolol 5mg OD).
- - Chronic Kidney Disease (CKD): ACEi or ARB is preferred (often in combination with CCB or diuretic).
- - Heart Failure: Include ACEi/ARB, Beta-blocker (specific ones), MRA (See HF section).
- - Pregnancy: AVOID ACEi/ARBs, diuretics. Safe options: Methyldopa, Labetalol, Nifedipine.
- - Secondary to Thyroid Disease: Consider adding Propranolol 40mg BID.
- Hypertensive Urgency (BP >180/110 mmHg without acute target organ damage): Admit, use oral combination therapy, lower BP gradually over 24-72 hours.
- Hypertensive Emergency (BP >180/110 mmHg WITH acute target organ damage): Admit, IV medications (e.g., IV Hydralazine 5-10mg slow push, IV Labetalol, IV Nitrates depending on complication), lower BP carefully (not too rapidly, except in aortic dissection). Treat specific complication (e.g., Furosemide for APO).
Monitoring
- Monitor BP response regularly (home monitoring useful).
- Assess adherence and side effects.
- Monitor electrolytes and renal function periodically (esp. with ACEi/ARB/Diuretics).
- Monitor lipids and glucose.
- Regularly assess for target organ damage (ECG, urinalysis, fundoscopy).
Complications
- Stroke (ischaemic and haemorrhagic)
- Myocardial Infarction (Heart Attack)
- Heart Failure
- Left Ventricular Hypertrophy (LVH)
- Chronic Kidney Disease / Renal Failure
- Peripheral Arterial Disease
- Aortic Aneurysm / Dissection
- Hypertensive Retinopathy -> Vision loss
- Hypertensive Encephalopathy
Prevention
- Maintain healthy weight.
- Reduce salt intake.
- Adopt healthy diet (DASH diet).
- Regular physical activity.
- Limit alcohol consumption.
- Avoid smoking.
- Manage stress.
- Regular BP screening, especially if risk factors present.
Patient education
- Explain hypertension is often lifelong and usually asymptomatic.
- Importance of lifestyle modifications (diet, exercise, salt, alcohol, smoking).
- Rationale for medication and critical importance of adherence (even when feeling well).
- How to take medications correctly, potential side effects.
- Importance of regular BP monitoring (clinic or home).
- Need for regular follow-up and lab tests.
- Signs/symptoms of complications (stroke, MI, HF) and when to seek urgent care.
- Risks of untreated hypertension.
Uganda-specific notes
High prevalence, often undiagnosed/uncontrolled. Lifestyle advice is crucial. Availability of different drug classes varies; UCG focuses on CCB, ACEi/ARB, Thiazides as core therapy. BP measurement technique and equipment calibration important. Secondary causes like renal disease should be considered.
References
- Uganda Clinical Guidelines (UCG) 2023
Chapter 4, Section 4.1.6 (including Hypertensive Emergencies/Urgency)